Orthofix Medical Inc. (OFIX): Capital Expenditures

Annual figures by period end, from SEC filings.

$34.63M

Year ended 2025-12-31

$44.09M

Trailing 12 months to 2026-06-30

+14.3%

3-year compound annual growth

2022-12-31 Capital Expenditures (USD) 2025-12-31

Period ended	Capital Expenditures	Change YoY	Source filing
2025-12-31	$34.63M	-0.7%	2026-02-24, From 2025-01-01
2024-12-31	$34.88M	-43.8%	2026-02-24, From 2024-01-01
2023-12-31	$62.05M	+167.9%	2026-02-24, From 2023-01-01
2022-12-31	$23.16M	n/a	2025-02-25, From 2022-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Capital Expenditures	Change YoY
Orthofix Medical Inc. (OFIX)	2025-12-31	$34.63M	-0.7%
Alphatec Holdings, Inc. (ATEC)	2025-12-31	$42.45M	-49.0%
iRhythm Holdings, Inc. (IRTC)	2025-12-31	$46.34M	+36.5%
Inspire Medical Systems, Inc. (INSP)	2025-12-31	$38.50M	-1.6%
Tandem Diabetes Care Inc (TNDM)	2025-12-31	$19.95M	+3.7%
NovoCure Ltd (NVCR)	2025-12-31	$26.65M	-37.8%
Embecta Corp. (EMBC)	2025-09-30	$9.30M	-41.1%
UFP Technologies Inc (UFPT)	2024-12-31	$9.66M	-8.0%
Bioventus Inc. (BVS)	2025-12-31	$2.56M	+154.7%

Compare OFIX, ATEC, IRTC, INSP side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗